<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01336855</url>
  </required_header>
  <id_info>
    <org_study_id>H8211-04743-22</org_study_id>
    <nct_id>NCT01336855</nct_id>
  </id_info>
  <brief_title>Collection of Blood for Multiple Collaborative Studies</brief_title>
  <official_title>Collection and Preservation of Blood and Serum Specimens From HIV Positive or HIV Negative Patients for Multiple Collaborative Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to confidentially collect blood from HIV-positive individuals and
      HIV-negative controls to provide basic scientists with specimens for collaborative studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HIV positive patients are currently the focus of multiple collaborative research studies,
      both at UCSF and other institutions. The aims of these research projects include improving
      the understanding of etiology, immunology, epidemiology and treatment of HIV. There are
      numerous requests from basic scientists at UCSF for collaborative studies on specimens,
      especially for blood, saliva and urine samples. Specimens may be used to test such things as
      virus characteristics, genotyping and/or phenotyping resistance, plasma drug concentrations,
      immune function or evidence of complications of HIV disease. The samples may also be tested
      for genetic factors that may be related to the course of HIV disease
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 1988</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All subjects will be asked detailed questions about their current health status and current sexual and drug use behavior. HIV positive subjects will additionally be asked specific to HIV-related conditions and treatment.</measure>
    <time_frame>Ongoing</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>HIV Positive</arm_group_label>
    <description>HIV-1 positive subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV negative subjects</arm_group_label>
    <description>HIV-1 seronegative control group</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, PBMCs, buffy coat, serum, saliva, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected based on positive or negative HIV antibody, depending on the
        study for which blood is being collected. Patients will be chosen from the Positive Health
        Practice populations at SFGH and UCSF, the General Medicine Clinic at the San Francisco
        Veterans Affairs Medical Center. HIV uninfected healthy volunteers with comparable risk
        factors to the HIV positive subjects will be recruited from the community.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort

          -  HIV-positive subjects naive to antiretroviral therapy

          -  HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6
             months

          -  Good venous access

          -  Able to provide informed consent

        Exclusion Criteria:

          -  Hemoglobin &lt; 9g/dl

          -  Hematocrit &lt; 27%

          -  Active treatment for cancer

          -  Hospitalization or IV antibiotic use within the last 4 months

          -  Immunosuppressive therapy within the last 4 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Deeks, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Californa, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca Hoh, M.S., R.D.</last_name>
    <phone>415-476-4082</phone>
    <phone_ext>139</phone_ext>
    <email>Rebecca.Hoh@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Viva Tai, MS. RD</last_name>
    <phone>415-476-4082</phone>
    <phone_ext>104</phone_ext>
    <email>Viva.Tai@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2011</study_first_submitted>
  <study_first_submitted_qc>April 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2011</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Observational</keyword>
  <keyword>Pathogenesis</keyword>
  <keyword>Immunology</keyword>
  <keyword>Virology</keyword>
  <keyword>Control</keyword>
  <keyword>Healthy control</keyword>
  <keyword>Men who have sex with men</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

